Wallace Owen B. (CIK 0001778843)

Latest company ownership

FULC - Fulcrum Therapeutics, Inc.

Role: Chief Scientific Officer

Shares held

6,350

Last filed at

Sep 14, 2020

Confidence Score

50.0

2025Q4

Confidence Score History

2020Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jul 8, 2020	Jul 9, 2020	Fulcrum Therapeutics, Inc.	Chief Scientific Officer	Sell	41.3	-2,951	-2.27%	✓	$59K
Jun 30, 2020	Jul 1, 2020	Fulcrum Therapeutics, Inc.	Chief Scientific Officer	Sell	55.0	-141	-0.11%	✓	$2.8K
May 28, 2020	Jun 1, 2020	Fulcrum Therapeutics, Inc.	Chief Scientific Officer	Sell	48.8	-2,232	-1.73%	✓	$44.6K
May 27, 2020	May 29, 2020	Fulcrum Therapeutics, Inc.	Chief Scientific Officer	Sell	53.8	-448	-0.35%	✓	$9K
May 26, 2020	May 28, 2020	Fulcrum Therapeutics, Inc.	Chief Scientific Officer	Sell	53.8	-412	-0.32%	✓	$8.2K
Feb 19, 2020	Feb 20, 2020	Fulcrum Therapeutics, Inc.	Chief Scientific Officer	Sell	37.5	-6,088	-4.57%	✓	$121.8K